Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Revenue

Medprin Regenerative Medical Technologies had revenue of 104.52M CNY in the quarter ending September 30, 2026, with 14.29% growth. This brings the company's total for the last twelve months to 413.92M, up 22.92% year-over-year. In the year 2025, Medprin Regenerative Medical Technologies had annual revenue of 368.83M with 32.46% growth. That makes Medprin Regenerative Medical Technologies the 26,341st largest company in the world by revenue and 4,620th in China.

• Revenue (ttm): 413.92M
• Revenue Growth: +22.92%
• P/S Ratio: 8.10
• Revenue / Employee: 926.00K
• Employees: 447
• Market Cap: 3.35B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Implanted Medical Devices 356.00M 96.5%
• Others 12.83M 3.5%

By Geography

Chart

• China 282.73M 76.7%
• Overseas 86.10M 23.3%

Fiscal year ended Dec 31, 2025 See the full SHE:301033 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	368.83M	90.39M	32.46%
Dec 31, 2024	278.44M	47.57M	20.61%
Dec 31, 2023	230.87M	35.62M	18.24%
Jan 1, 2023	195.25M	41.47M	26.96%
Jan 1, 2022	153.79M	30.27M	24.51%

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error